As of November 6, 2026, 9 holders' latest Schedule 13D or 13G filings report owning 5% or more of Universe Pharmaceuticals INC. The largest reported stake is Origin Force Intelligence Limited's, at 18.3%. 10 filings are on record since January 7, 2026 (Schedule 13G, September 1, 2026).
Who owns Universe Pharmaceuticals INC?
Sell to companies like Universe Pharmaceuticals INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Origin Force Intelligence Limited · Sole voting: 0 · Shared voting: 916,759 · Sole dispositive: 0 · Shared dispositive: 916,759 · SCHEDULE 13G, 2026-09-01
- · Reporting person: Orbis BioCapital Limited · Sole voting: 0 · Shared voting: 499,926 · Sole dispositive: 0 · Shared dispositive: 499,926 · SCHEDULE 13G, 2026-09-01
- · Reporting person: Whitmore Limited · Sole voting: 0 · Shared voting: 499,424 · Sole dispositive: 0 · Shared dispositive: 499,424 · SCHEDULE 13G, 2026-09-01
- · Reporting person: Horizon Ridge Limited · Sole voting: 0 · Shared voting: 499,424 · Sole dispositive: 0 · Shared dispositive: 499,424 · SCHEDULE 13G, 2026-09-01
- · Reporting person: Clever Way Global Limited · Sole voting: 0 · Shared voting: 498,922 · Sole dispositive: 0 · Shared dispositive: 498,922 · SCHEDULE 13G, 2026-09-01
Universe Pharmaceuticals INC has 10 Schedule 13D or 13G filings on record since 2026-01-07. 9 holders' latest filing reports 5% or more of class a ordinary shares. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Origin Force Intelligence Limited | 18.3% | 916,759 | SCHEDULE 13G, 2026-09-01 | 2026-07-27 |
| 13.58% | 87,967 | SCHEDULE 13D, 2026-05-21 | 2026-05-07 | |
| Orbis BioCapital Limited | 9.98% | 499,926 | SCHEDULE 13G, 2026-09-01 | 2026-07-27 |
| Whitmore Limited | 9.97% | 499,424 | SCHEDULE 13G, 2026-09-01 | 2026-07-27 |
| Horizon Ridge Limited | 9.97% | 499,424 | SCHEDULE 13G, 2026-09-01 | 2026-07-27 |
| Clever Way Global Limited | 9.96% | 498,922 | SCHEDULE 13G, 2026-09-01 | 2026-07-27 |
| Meridian Prosperous Limited | 9.96% | 498,922 | SCHEDULE 13G, 2026-09-01 | 2026-07-30 |
| Star Voyage International Limited | 9.94% | 497,917 | SCHEDULE 13G, 2026-09-01 | 2026-07-27 |
| August Luck Global Limited | 9.29% | 465,258 | SCHEDULE 13G, 2026-09-01 | 2026-07-27 |
| Sabby Management, LLC | 4.9% | 28,111 | SCHEDULE 13G/A, 2026-01-07 | 2025-12-31 |
Holding shares or following this stake? See who's behind Universe Pharmaceuticals INC and the warning signs.
Free to see. No signup.
Keep reading
More on Universe Pharmaceuticals INC and the records around it.
Universe Pharmaceuticals INC elsewhere on the record
Companies that share a holder
- SABBY MANAGEMENT, LLC also filed stake reports on 15 other companies: Globavend Holdings Ltd (Jan 2026), Jiuzi Holdings, Inc. (Jan 2026), Tempest Therapeutics, Inc. (Jan 2026)
Watch Universe Pharmaceuticals INC
Get an email when Universe Pharmaceuticals INC files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Universe Pharmaceuticals INC?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Universe Pharmaceuticals INC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Universe Pharmaceuticals INC covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
10 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Origin Force Intelligence Limited | 0 | 916,759 | 0 | 916,759 | SCHEDULE 13G, 2026-09-01 |
| Piao Ye | 0 | 916,759 | 0 | 916,759 | SCHEDULE 13G, 2026-09-01 |
| Orbis BioCapital Limited | 0 | 499,926 | 0 | 499,926 | SCHEDULE 13G, 2026-09-01 |
| Chunhua Zheng | 0 | 499,926 | 0 | 499,926 | SCHEDULE 13G, 2026-09-01 |
| Whitmore Limited | 0 | 499,424 | 0 | 499,424 | SCHEDULE 13G, 2026-09-01 |
| Chengming Tang | 0 | 499,424 | 0 | 499,424 | SCHEDULE 13G, 2026-09-01 |
| Horizon Ridge Limited | 0 | 499,424 | 0 | 499,424 | SCHEDULE 13G, 2026-09-01 |
| Shan Xie | 0 | 499,424 | 0 | 499,424 | SCHEDULE 13G, 2026-09-01 |
| Clever Way Global Limited | 0 | 498,922 | 0 | 498,922 | SCHEDULE 13G, 2026-09-01 |
| Lu Yang | 0 | 498,922 | 0 | 498,922 | SCHEDULE 13G, 2026-09-01 |
| Meridian Prosperous Limited | 0 | 498,922 | 0 | 498,922 | SCHEDULE 13G, 2026-09-01 |
| Shanshan Lu | 0 | 498,922 | 0 | 498,922 | SCHEDULE 13G, 2026-09-01 |
| Star Voyage International Limited | 0 | 497,917 | 0 | 497,917 | SCHEDULE 13G, 2026-09-01 |
| Xuncheng Chen | 0 | 497,917 | 0 | 497,917 | SCHEDULE 13G, 2026-09-01 |
| August Luck Global Limited | 0 | 465,258 | 0 | 465,258 | SCHEDULE 13G, 2026-09-01 |
| Xuefeng Li | 0 | 465,258 | 0 | 465,258 | SCHEDULE 13G, 2026-09-01 |
The latest filing identifies Universe Pharmaceuticals INC by CUSIP G9442G138 and gives its principal executive office as 265 Jingjiu Avenue, Jinggangshan Economic and Technological, Ji'an, Jiangxi (SCHEDULE 13G, 2026-09-01).
Purpose of Transaction (Item 4)
Gang Lai
Gang Lai serves as Chief Executive Officer and Chairman of the Board of Directors of the Issuer. In such capacities, Gang Lai may engage in communications with the Issuer's Board of Directors, members of management, other shareholders, financial and legal advisers, and other parties regarding the Issuer, including but not limited to the Issuer's operations, governance and control. In addition, in these capacities, he may have influence over the corporate activities of the Issuer, including activities which may relate to items described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. Except as set forth herein, Gang Lai does not have any plans or proposals which relate to, or could result in, any of the matters referred to in paragraphs (a) through (j), inclusive, of the instructions to Item 4 of Schedule 13D. He may, at any time and from time to time, review or reconsider his position and/or change his purpose and/or formulate plans or proposals with respect thereto. Gang Lai acquired the ordinary shares pursuant to the Equity Grant and intends to maintain his holding in the Issuer on a continuing basis. Nevertheless, he may acquire additional shares of the Issuer or sell or otherwise dispose of any or all of the shares that he beneficially owns.Item 4 of the SCHEDULE 13D filed 2026-05-21
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-01-07 | Sabby Management, LLC | 4.9% | SCHEDULE 13G/A |
| 2026-05-21 | Gang Lai | 13.58% | SCHEDULE 13D |
| 2026-09-01 | Whitmore Limited | 9.97% | SCHEDULE 13G |
| 2026-09-01 | Orbis BioCapital Limited | 9.98% | SCHEDULE 13G |
| 2026-09-01 | Clever Way Global Limited | 9.96% | SCHEDULE 13G |
| 2026-09-01 | Origin Force Intelligence Limited | 18.3% | SCHEDULE 13G |
| 2026-09-01 | Horizon Ridge Limited | 9.97% | SCHEDULE 13G |
| 2026-09-01 | Meridian Prosperous Limited | 9.96% | SCHEDULE 13G |
| 2026-09-01 | August Luck Global Limited | 9.29% | SCHEDULE 13G |
| 2026-09-01 | Star Voyage International Limited | 9.94% | SCHEDULE 13G |
Questions about who owns Universe Pharmaceuticals INC
Who owns Universe Pharmaceuticals INC?
On this page, 9 holders' latest ownership filings report 5% or more of Universe Pharmaceuticals INC: Origin Force Intelligence Limited (18.3%, Schedule 13G, filed 2026-09-01), Gang Lai (13.58%, Schedule 13D, filed 2026-05-21), Orbis BioCapital Limited (9.98%, Schedule 13G, filed 2026-09-01), Whitmore Limited (9.97%, Schedule 13G, filed 2026-09-01) and Horizon Ridge Limited (9.97%, Schedule 13G, filed 2026-09-01); 4 more are listed above.
Who are the largest shareholders of Universe Pharmaceuticals INC?
By the share each holder's latest filing reports, the largest holders of Universe Pharmaceuticals INC on this page are Origin Force Intelligence Limited (18.3%), Gang Lai (13.58%) and Orbis BioCapital Limited (9.98%).
When did Origin Force Intelligence Limited buy into Universe Pharmaceuticals INC?
The filings give report dates, not purchase dates. The earliest filing from Origin Force Intelligence Limited on this page is the Schedule 13G, filed 2026-09-01, reporting 18.3%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 10 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Universe Pharmaceuticals INC. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.